Amneal Pharmaceuticals Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/E Ratio67.357.41
Forward P/E11.6911.922.715.657.07
P/S Ratio0.880.780.140.340.34
P/B Ratio-55.1030.351.441.861.89
Price/FCF10.456.2318.493.752.13
Price/OCF8.325.384.632.961.78
PEG Ratio0.510.510.180.662.65
Enterprise Value Ratios
EV/Revenue1.821.851.351.611.74
EV/EBITDA8.698.856.797.499.11
EV/EBIT14.5916.3414.9415.5723.83
EV/FCF21.6414.84183.2917.6710.94
Profitability & Returns
Return on Equity (ROE)-8.81%-0.36%-0.86%0.05%0.20%
Return on Assets (ROA)0.06%0.05%0.03%0.03%0.02%
Return on Invested Capital (ROIC)0.14%0.09%0.07%0.05%0.05%
Return on Capital Employed (ROCE)0.15%0.10%0.07%0.07%0.04%
Leverage & Solvency Ratios
Debt/Equity-58.2244.8713.627.528.41
Debt/EBITDA4.285.266.156.157.36
Debt/FCF11.059.21174.5015.139.46
Liquidity Ratios
Current Ratio1.411.631.882.252.29
Quick Ratio0.810.871.091.391.49
Efficiency Ratios
Asset Turnover0.800.660.570.530.52
Inventory Turnover2.982.752.792.673.08
Yield & Distribution Ratios
Earnings Yield-0.05%-0.05%-0.43%0.01%0.14%
FCF Yield0.10%0.16%0.05%0.27%0.47%
Buyback Yield-0.75%-0.17%0.01%-0.02%-0.13%
Total Return-0.75%-0.17%0.01%-0.02%-0.13%